Optimization of a single HPLC-PDA method for quantifying Metformin, Gliclazide, Pioglitazone, Dapagliflozin, Empagliflozin, Saxagliptin, Linagliptin and Teneligliptin using central composite design.

Ravi Kant Ramesh Babu Bodla Garima Kapoor Rubina Bhutani

Bioorg Chem

Pharmaceutical Chemistry Department, Delhi Institute of Pharmaceutical Sciences & Research, University of Delhi, Sector 3, Pushp Vihar, Mehrauli Badarpur Road, New Delhi 110017, India.

Published: October 2019

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.bioorg.2019.103111	DOI Listing

Publication Analysis

Top Keywords

optimization single

single hplc-pda

hplc-pda method

method quantifying

quantifying metformin

metformin gliclazide

gliclazide pioglitazone

pioglitazone dapagliflozin

dapagliflozin empagliflozin

empagliflozin saxagliptin

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!